|
1
|
Sun H, Saeedi P, Karuranga S, Pinkepank M,
Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et
al: IDF diabetes atlas: Global, regional and country-level diabetes
prevalence estimates for 2021 and projections for 2045. Diabetes
Res Clin Pract. 183(109119)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Papatheodorou K, Papanas N, Banach M,
Papazoglou D and Edmonds M: Complications of diabetes 2016. J
Diabetes Res. 2016(6989453)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lotfy M, Adeghate J, Kalasz H, Singh J and
Adeghate E: Chronic complications of diabetes mellitus: A mini
review. Curr Diabetes Rev. 13:3–10. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mariye Zemicheal T, Bahrey Tadesse D,
Tasew Atalay H, Teklay Weldesamuel G, Gebremichael GB, Tesfay HN
and Haile TG: Determinants of diabetic nephropathy among diabetic
patients in general public hospitals of tigray, ethiopia, 2018/19.
Int J Endocrinol. 2020(6396483)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nagib AM, Elsayed Matter Y, Gheith OA,
Refaie AF, Othman NF and Al-Otaibi T: diabetic nephropathy
following posttransplant diabetes mellitus. Exp Clin Transplant.
17:138–146. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Koye DN, Magliano DJ, Nelson RG and Pavkov
ME: The global epidemiology of diabetes and kidney disease. Adv
Chronic Kidney Dis. 25:121–132. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rao Kondapally Seshasai S, Kaptoge S,
Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal
KJ, Gillum RF, Holme I, et al: Diabetes mellitus, fasting glucose,
and risk of cause-specific death. N Engl J Med. 364:829–841.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yamout H, Lazich I and Bakris GL: Blood
pressure, hypertension, RAAS blockade, and drug therapy in diabetic
kidney disease. Adv Chronic Kidney Dis. 21:281–286. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Doulton TW: ACE inhibitor-angiotensin
receptor blocker combinations: A clinician's perspective. Mini Rev
Med Chem. 6:491–497. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Forclaz A, Maillard M, Nussberger J,
Brunner HR and Burnier M: Angiotensin II receptor blockade: Is
there truly a benefit of adding an ACE inhibitor? Hypertension.
41:31–36. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shen MR, He Y and Shi SM: Development of
chromatographic technologies for the quality control of traditional
Chinese medicine in the Chinese pharmacopoeia. J Pharm Anal.
11:155–162. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Song Y, Yang J, Bai WL and Ji WY:
Antitumor and immunoregulatory effects of Astragalus on
nasopharyngeal carcinoma in vivo and in vitro. Phytother Res.
25:909–915. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Song J, Li J, Zheng SR, Jin Y and Huang Y:
Anti-inflammatory and immunoregulatory effects of Yupingfeng powder
on chronic bronchitis rats. Chin J Integr Med. 19:353–359.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Qin Q, Niu J, Wang Z, Xu W, Qiao Z and Gu
Y: Astragalus embranaceus extract activates immune response
in macrophages via heparanase. Molecules. 17:7232–7240.
2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jung Y, Jerng U and Lee S: A systematic
review of anticancer effects of radix astragali. Chin J Integr Med.
22:225–236. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jin M, Zhao K, Huang Q and Shang P:
Structural features and biological activities of the
polysaccharides from Astragalus membranaceus. Int J Biol
Macromol. 64:257–266. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen Z, Liang H, Yan X, Liang Q, Bai Z,
Xie T, Dai J, Zhao X and Xiao Y: Astragalus polysaccharide
promotes autophagy and alleviates diabetic nephropathy by targeting
the lncRNA Gm41268/PRLR pathway. Ren Fail.
45(2284211)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Meng X, Wei M, Wang D, Qu X, Zhang K,
Zhang N and Li X: Astragalus polysaccharides protect renal
function and affect the TGF-β/Smad signaling pathway in
streptozotocin-induced diabetic rats. J Int Med Res.
48(300060520903612)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang YW, Wu CY and Cheng JT: Merit of
Astragalus polysaccharide in the improvement of early
diabetic nephropathy with an effect on mRNA expressions of
NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced
diabetic rats. J Ethnopharmacol. 114:387–392. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Guo M, Gao J, Jiang L and Dai Y:
Astragalus polysaccharide ameliorates renal inflammatory
responses in a diabetic nephropathy by suppressing the TLR4/NF-κB
pathway. Drug Des Devel Ther. 17:2107–2118. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Siddaway AP, Wood AM and Hedges LV: How to
do a systematic review: A best practice guide for conducting and
reporting narrative reviews, meta-analyses, and meta-syntheses.
Annu Rev Psychol. 70:747–770. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Levy N: The use of animal as models:
Ethical considerations. Int J Stroke. 7:440–442. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ioannidis JP, Greenland S, Hlatky MA,
Khoury MJ, Macleod MR, Moher D, Schulz KF and Tibshirani R:
Increasing value and reducing waste in research design, conduct,
and analysis. Lancet. 383:166–175. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Sandercock G: The standard error/standard
deviation mix-up: Potential impacts on meta-analyses in sports
medicine. Sports Med. 54:1723–1732. 2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hooijmans CR, Rovers MM, de Vries RB,
Leenaars M, Ritskes-Hoitinga M and Langendam MW: SYRCLE's risk of
bias tool for animal studies. BMC Med Res Methodol.
14(43)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wong MCS, Chan CH, Lin J, Huang JLW, Huang
J, Fang Y, Cheung WWL, Yu CP, Wong JCT, Tse G, et al: Lower
relative contribution of positive family history to colorectal
cancer risk with increasing age: A systematic review and
meta-analysis of 9.28 million individuals. Am J Gastroenterol.
113:1819–1827. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mao SM, Li CD, Li JJ and Kang B: Effect of
Astragalus polysaccharide on expression of aquaporin-2 in
kidney of diabetic rats and its protective effect on kidney. Chin J
Geriatr. 30:2301–2303. 2010.(In Chinese).
|
|
30
|
Liu XF, Feng J, Wang SJ and Zuo H: Effect
and mechanism of Astragalus polysaccharide on oxidative
stress and autophagy in diabetic nephropathy rats. J Shanxi Med
Univ. 54:343–351. 2023.(In Chinese). doi:
10.13753/j.issn.1007-6611.2023.03.010.
|
|
31
|
Li ZJ and Zhang Y, Liu YM, Lu HY, Li YL
and Zhang Y: Effects of Astragalus polysaccharide on the
expression of nephrin and podocin in podocytes of rats with early
diabetic nephropathy. Chin J Pathophysiol. 27:1772–1776. 2011.(In
Chinese). doi: 10.3969/j.issn.1000-4718.2011.09.021.
|
|
32
|
Wu D, Zhang QH, He LQ and Yang SS:
Astragalus polysaccharide regulates PI3K/AKT pathway to
improve renal injury in diabetic rats. Biotechnology. 1–7. 2023.(In
Chinese). https://link.cnki.net/urlid/23.1319.Q.20240306.1042.004.
|
|
33
|
Feng H, Wu T, Zhou Q, Li H, Liu T, Ma X
and Yue R: Protective effect and possible mechanisms of artemisinin
and its derivatives for diabetic nephropathy: A systematic review
and meta-analysis in animal models. Oxid Med Cell Longev.
2022(5401760)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang Z, Zhao H, Ge D, Wang S and Qi B:
β-casomorphin-7 ameliorates sepsis-induced acute kidney injury by
targeting NF-κB pathway. Med Sci Monit. 25:121–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Livingston MJ, Ding HF, Huang S, Hill JA,
Yin XM and Dong Z: Persistent activation of autophagy in kidney
tubular cells promotes renal interstitial fibrosis during
unilateral ureteral obstruction. Autophagy. 12:976–998.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kay AM, Simpson CL and Stewart JA Jr: The
role of AGE/RAGE signaling in diabetes-mediated vascular
calcification. J Diabetes Res. 2016(6809703)2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sanajou D, Ghorbani Haghjo A, Argani H and
Aslani S: AGE-RAGE axis blockade in diabetic nephropathy: Current
status and future directions. Eur J Pharmacol. 833:158–164.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bai C, Sun Y, Pan X, Yang J, Li X, Wu A,
Qin D, Cao S, Zou W and Wu J: Antitumor effects of trimethylellagic
acid isolated from sanguisorba officinalis L. on colorectal cancer
via angiogenesis inhibition and apoptosis induction. Front
Pharmacol. 10(1646)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sarker KP, Wilson SM and Bonni S: SnoN is
a cell type-specific mediator of transforming growth factor-beta
responses. J Biol Chem. 280:13037–13046. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Price SA, Agthong S, Middlemas AB and
Tomlinson DR: Mitogen-activated protein kinase p38 mediates reduced
nerve conduction velocity in experimental diabetic neuropathy:
Interactions with aldose reductase. Diabetes. 53:1851–1856.
2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rivero A, Mora C, Muros M, García J,
Herrera H and Navarro-González JF: Pathogenic perspectives for the
role of inflammation in diabetic nephropathy. Clin Sci (Lond).
116:479–492. 2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Navarro-González JF, Mora-Fernández C,
Muros de Fuentes M and García-Pérez J: Inflammatory molecules and
pathways in the pathogenesis of diabetic nephropathy. Nat Rev
Nephrol. 7:327–340. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu L, Zheng T, Wang F, Wang N, Song Y, Li
M, Li L, Jiang J and Zhao W: Pro12Ala polymorphism in the PPARG
gene contributes to the development of diabetic nephropathy in
Chinese type 2 diabetic patients. Diabetes Care. 33:144–149.
2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Dugan LL, You YH, Ali SS, Diamond-Stanic
M, Miyamoto S, DeCleves AE, Andreyev A, Quach T, Ly S, Shekhtman G,
et al: AMPK dysregulation promotes diabetes-related reduction of
superoxide and mitochondrial function. J Clin Invest.
123:4888–4899. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Jäger S, Handschin C, St-Pierre J and
Spiegelman BM: AMP-activated protein kinase (AMPK) action in
skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl
Acad Sci USA. 104:12017–12022. 2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Perrin S: Preclinical research: Make mouse
studies work. Nature. 507:423–425. 2014.PubMed/NCBI View Article : Google Scholar
|
